146 related articles for article (PubMed ID: 33833946)
1. Performance of International AIDS Vaccine Initiative African clinical research laboratories in standardised ELISpot and peripheral blood mononuclear cell processing in support of HIV vaccine clinical trials.
Langat RK; Farah B; Indangasi J; Ogola S; Omosa-Manyonyi G; Anzala O; Bizimana J; Tekirya E; Ngetsa C; Silwamba M; Muyanja E; Chetty P; Jangano M; Hills N; Gilmour J; Dally L; Cox JH; Hayes P
Afr J Lab Med; 2021; 10(1):1056. PubMed ID: 33833946
[TBL] [Abstract][Full Text] [Related]
2. Concordant proficiency in measurement of T-cell immunity in human immunodeficiency virus vaccine clinical trials by peripheral blood mononuclear cell and enzyme-linked immunospot assays in laboratories from three continents.
Boaz MJ; Hayes P; Tarragona T; Seamons L; Cooper A; Birungi J; Kitandwe P; Semaganda A; Kaleebu P; Stevens G; Anzala O; Farah B; Ogola S; Indangasi J; Mhlanga P; Van Eeden M; Thakar M; Pujari A; Mishra S; Goonetilleke N; Moore S; Mahmoud A; Sathyamoorthy P; Mahalingam J; Narayanan PR; Ramanathan VD; Cox JH; Dally L; Gill DK; Gilmour J
Clin Vaccine Immunol; 2009 Feb; 16(2):147-55. PubMed ID: 19091991
[TBL] [Abstract][Full Text] [Related]
3. Establishment and maintenance of a PBMC repository for functional cellular studies in support of clinical vaccine trials.
Sambor A; Garcia A; Berrong M; Pickeral J; Brown S; Rountree W; Sanchez A; Pollara J; Frahm N; Keinonen S; Kijak GH; Roederer M; Levine G; D'Souza MP; Jaimes M; Koup R; Denny T; Cox J; Ferrari G
J Immunol Methods; 2014 Jul; 409():107-16. PubMed ID: 24787274
[TBL] [Abstract][Full Text] [Related]
4. Results of an ELISPOT proficiency panel conducted in 11 laboratories participating in international human immunodeficiency virus type 1 vaccine trials.
Cox JH; Ferrari G; Kalams SA; Lopaczynski W; Oden N; D'souza MP;
AIDS Res Hum Retroviruses; 2005 Jan; 21(1):68-81. PubMed ID: 15665646
[TBL] [Abstract][Full Text] [Related]
5. The Center for HIV/AIDS Vaccine Immunology (CHAVI) multi-site quality assurance program for cryopreserved human peripheral blood mononuclear cells.
Sarzotti-Kelsoe M; Needham LK; Rountree W; Bainbridge J; Gray CM; Fiscus SA; Ferrari G; Stevens WS; Stager SL; Binz W; Louzao R; Long KO; Mokgotho P; Moodley N; Mackay M; Kerkau M; McMillion T; Kirchherr J; Soderberg KA; Haynes BF; Denny TN
J Immunol Methods; 2014 Jul; 409():21-30. PubMed ID: 24910414
[TBL] [Abstract][Full Text] [Related]
6. Benefits of a comprehensive quality program for cryopreserved PBMC covering 28 clinical trials sites utilizing an integrated, analytical web-based portal.
Ducar C; Smith D; Pinzon C; Stirewalt M; Cooper C; McElrath MJ; Hural J;
J Immunol Methods; 2014 Jul; 409():9-20. PubMed ID: 24709391
[TBL] [Abstract][Full Text] [Related]
7. Proficiency tests to evaluate the impact on assay outcomes of harmonized influenza-specific Intracellular Cytokine Staining (ICS) and IFN-ɣ Enzyme-Linked ImmunoSpot (ELISpot) protocols.
Waerlop G; Leroux-Roels G; Pagnon A; Begue S; Salaun B; Janssens M; Medaglini D; Pettini E; Montomoli E; Gianchecchi E; Lambe T; Godfrey L; Bull M; Bellamy D; Amdam H; Bredholt G; Cox RJ; Clement F
J Immunol Methods; 2023 Dec; 523():113584. PubMed ID: 37918618
[TBL] [Abstract][Full Text] [Related]
8. Equivalence of ELISpot assays demonstrated between major HIV network laboratories.
Gill DK; Huang Y; Levine GL; Sambor A; Carter DK; Sato A; Kopycinski J; Hayes P; Hahn B; Birungi J; Tarragona-Fiol T; Wan H; Randles M; Cooper AR; Ssemaganda A; Clark L; Kaleebu P; Self SG; Koup R; Wood B; McElrath MJ; Cox JH; Hural J; Gilmour J
PLoS One; 2010 Dec; 5(12):e14330. PubMed ID: 21179404
[TBL] [Abstract][Full Text] [Related]
9. The External Quality Assurance Oversight Laboratory (EQAPOL) proficiency program for IFN-gamma enzyme-linked immunospot (IFN-γ ELISpot) assay.
Sanchez AM; Rountree W; Berrong M; Garcia A; Schuetz A; Cox J; Frahm N; Manak M; Sarzotti-Kelsoe M; D'Souza MP; Denny T; Ferrari G
J Immunol Methods; 2014 Jul; 409():31-43. PubMed ID: 24685833
[TBL] [Abstract][Full Text] [Related]
10. Optimization of Peripheral Blood Mononuclear Cell Processing for Improved Clinical ELISpot Assay Performance.
Li X; He S; Thomas J; Wu B; Yang TY; Swanson M
AAPS J; 2023 Sep; 25(6):93. PubMed ID: 37770755
[TBL] [Abstract][Full Text] [Related]
11. Evaluation of the interlaboratory concordance in quantification of human immunodeficiency virus-specific T cells with a gamma interferon enzyme-linked immunospot assay.
Samri A; Durier C; Urrutia A; Sanchez I; Gahery-Segard H; Imbart S; Sinet M; Tartour E; Aboulker JP; Autran B; Venet A;
Clin Vaccine Immunol; 2006 Jun; 13(6):684-97. PubMed ID: 16760328
[TBL] [Abstract][Full Text] [Related]
12. Results and harmonization guidelines from two large-scale international Elispot proficiency panels conducted by the Cancer Vaccine Consortium (CVC/SVI).
Janetzki S; Panageas KS; Ben-Porat L; Boyer J; Britten CM; Clay TM; Kalos M; Maecker HT; Romero P; Yuan J; Kast WM; Hoos A;
Cancer Immunol Immunother; 2008 Mar; 57(3):303-15. PubMed ID: 17721781
[TBL] [Abstract][Full Text] [Related]
13. Optimal blood mononuclear cell isolation procedures for gamma interferon enzyme-linked immunospot testing of healthy Swedish and Tanzanian subjects.
Nilsson C; Aboud S; Karlén K; Hejdeman B; Urassa W; Biberfeld G
Clin Vaccine Immunol; 2008 Apr; 15(4):585-9. PubMed ID: 18287577
[TBL] [Abstract][Full Text] [Related]
14. Introduction to a Special Issue of the Journal of Immunological Methods: Building global resource programs to support HIV/AIDS clinical trial studies.
Sanchez AM; Denny TN; O'Gorman M
J Immunol Methods; 2014 Jul; 409():1-5. PubMed ID: 24910413
[TBL] [Abstract][Full Text] [Related]
15. Effect of cryopreservation of peripheral blood mononuclear cells (PBMCs) on the variability of an antigen-specific memory B cell ELISpot.
Trück J; Mitchell R; Thompson AJ; Morales-Aza B; Clutterbuck EA; Kelly DF; Finn A; Pollard AJ
Hum Vaccin Immunother; 2014; 10(8):2490-6. PubMed ID: 25424961
[TBL] [Abstract][Full Text] [Related]
16. ELISPOT assays provide reproducible results among different laboratories for T-cell immune monitoring--even in hands of ELISPOT-inexperienced investigators.
Zhang W; Caspell R; Karulin AY; Ahmad M; Haicheur N; Abdelsalam A; Johannesen K; Vignard V; Dudzik P; Georgakopoulou K; Mihaylova A; Silina K; Aptsiauri N; Adams V; Lehmann PV; McArdle S
J Immunotoxicol; 2009 Dec; 6(4):227-34. PubMed ID: 19908941
[TBL] [Abstract][Full Text] [Related]
17. Establishing acceptance criteria for cell-mediated-immunity assays using frozen peripheral blood mononuclear cells stored under optimal and suboptimal conditions.
Smith JG; Joseph HR; Green T; Field JA; Wooters M; Kaufhold RM; Antonello J; Caulfield MJ
Clin Vaccine Immunol; 2007 May; 14(5):527-37. PubMed ID: 17376862
[TBL] [Abstract][Full Text] [Related]
18. Standardization of sensitive human immunodeficiency virus coculture procedures and establishment of a multicenter quality assurance program for the AIDS Clinical Trials Group. The NIH/NIAID/DAIDS/ACTG Virology Laboratories.
Hollinger FB; Bremer JW; Myers LE; Gold JW; McQuay L
J Clin Microbiol; 1992 Jul; 30(7):1787-94. PubMed ID: 1629336
[TBL] [Abstract][Full Text] [Related]
19. Evaluation of a mosaic HIV-1 vaccine in a multicentre, randomised, double-blind, placebo-controlled, phase 1/2a clinical trial (APPROACH) and in rhesus monkeys (NHP 13-19).
Barouch DH; Tomaka FL; Wegmann F; Stieh DJ; Alter G; Robb ML; Michael NL; Peter L; Nkolola JP; Borducchi EN; Chandrashekar A; Jetton D; Stephenson KE; Li W; Korber B; Tomaras GD; Montefiori DC; Gray G; Frahm N; McElrath MJ; Baden L; Johnson J; Hutter J; Swann E; Karita E; Kibuuka H; Mpendo J; Garrett N; Mngadi K; Chinyenze K; Priddy F; Lazarus E; Laher F; Nitayapan S; Pitisuttithum P; Bart S; Campbell T; Feldman R; Lucksinger G; Borremans C; Callewaert K; Roten R; Sadoff J; Scheppler L; Weijtens M; Feddes-de Boer K; van Manen D; Vreugdenhil J; Zahn R; Lavreys L; Nijs S; Tolboom J; Hendriks J; Euler Z; Pau MG; Schuitemaker H
Lancet; 2018 Jul; 392(10143):232-243. PubMed ID: 30047376
[TBL] [Abstract][Full Text] [Related]
20. Development and implementation of an international proficiency testing program for a neutralizing antibody assay for HIV-1 in TZM-bl cells.
Todd CA; Greene KM; Yu X; Ozaki DA; Gao H; Huang Y; Wang M; Li G; Brown R; Wood B; D'Souza MP; Gilbert P; Montefiori DC; Sarzotti-Kelsoe M
J Immunol Methods; 2012 Jan; 375(1-2):57-67. PubMed ID: 21968254
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
